Yahoo Web Search

Search results

1. • 

     Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q1 2024 Earnings Call Transcript

     Insider Monkey via Yahoo Finance· 6 days ago

     Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q1 2024 Earnings Call Transcript May 8, 2024 Vanda...

2. • 

     It Took Me Years to Find the Right Psoriatic Arthritis Medication

     Verywell Health via Yahoo News· 2 days ago

     After being diagnosed with psoriatic arthritis in 2016, it took LB Herbert years to find a psoriatic...

3. • Arcutis Biotherapeutics Inc (ARQT) Q1 2024 Earnings Call Transcr

     Guru Focus· 2 days ago

     For the complete transcript of the earnings call, please refer to the full earnings call transcript. Arcutis Biotherapeutics Inc (ARQT, Financial) reported strong revenue growth in Q1 2024, ...

4. • StockNews.com Initiates Coverage on Can-Fite BioPharma (NYSE:CANF)

     ETF DAILY NEWS· 5 days ago

     StockNews.com began coverage on shares of Can-Fite BioPharma (NYSE:CANF – Free Report) in a research report released on Wednesday morning. The brokerage issued a hold rating on the stock. Can-Fite ...

5. • 

     Stelara interactions: Other medications, alcohol, and more

     Medical News Today· 6 days ago

     Stelara (ustekinumab) is a brand-name injectable drug prescribed for certain autoimmune conditions....

6. • 

     The Best Appetite Suppressants and Diet Pills To Control Hunger and Boost Metabolism in 2024

     Men's Journal· 10 hours ago

     Curb cravings and sustain your energy with safe and effective appetite suppressants. When paired...

7. • Q1 2024 Vanda Pharmaceuticals Inc Earnings Call

     Thomson Reuters StreetEvents via Yahoo Finance· 7 days ago

     Currently approved as a once-a-day oral treatment for people with multiple sclerosis. PONVORY has a differentiated profile from other drugs in the class with high specificity ...

8. • 

     SRMC opens new infusion center

     The Alliance Review via Yahoo News· 7 days ago

     The Infusion Center provides intravenous medications and treatments for a variety of illnesses. Outpatient infusion therapies are provided to those with...

9. • Celltrion USA's adalimumab-aaty biosimilar to HUMIRA® now available at low wholesale acquisition...

     Rome Sentinel· 6 days ago

     Adalimumab-aaty is also available from Celltrion USA under the brand name YUFLYMA®, which launched in July 2023 and is available at a 5% discount to the current WAC list price of HUMIRA. Adalimumab-aaty ...

10. • 

      Earnings call: Almirall targets leadership in medical dermatology with Q1 growth By Investing.com

      Investing.com· 2 days ago

      Almirall, the pharmaceutical company specializing in medical dermatology, outlined a solid start to...